Literature DB >> 23998197

Thyroid gland invasion in total laryngectomy and total laryngopharyngectomy: a systematic review and meta-analysis of the English literature.

R Kumar1, M Drinnan, M Robinson, D Meikle, F Stafford, A Welch, I Zammit-Maempel, V Paleri.   

Abstract

BACKGROUND: Advanced laryngeal and hypopharyngeal squamous cell carcinomas carry an inherent risk of invading thyroid parenchyma leading to the incorporation of a hemithyroidectomy or total thyroidectomy as part of a total laryngectomy. In some centres, thyroid gland removal occurs routinely during surgery for T3 and T4 laryngopharyngeal carcinoma. However, the incidence of invasion is low, and therefore, thyroid-sparing surgery must be considered for select cases. OBJECTIVE OF REVIEW: The primary goal of the review is to assess the true incidence of thyroid gland invasion in laryngopharyngeal carcinoma. Utilising this data we aim to identify risk factors and clinical predictors of thyroid gland invasion to facilitate in a more targeted approach in the surgical management of advanced laryngopharyngeal carcinoma. TYPE OF REVIEW: A systematic review and meta-analysis of all published data and review of case series at Newcastle upon Tyne Hospitals (NuTH). SEARCH STRATEGY: MEDLINE (1946-2012) and EMBASE (1980-2012) were searched. EVALUATION
METHOD: A single reviewer conducted the systematic review with a follow-up ancestry search. Studies publishing case series of T3 and T4 laryngeal and hypopharyngeal carcinoma treated by total laryngectomy or laryngopharyngectomy and partial or total thyroidectomy, with pathological assessment for thyroid gland invasion rates were selected. Articles published prior to 1977 were excluded due to the advent of whole organ sectioning.
RESULTS: The literature search identified 16 studies suitable for inclusion, with 1180 cases. The NuTH case series identified 107 patients. The overall pooled incidence of thyroid gland invasion in 1287 patients is 10.7% (95% CI 7.6-14.2). Patients with primary subglottic tumours (relative risk 7.5; 95% CI 4.3-13.0) and disease extension into the subglottis (relative risk 4.3; 95% CI 2.5-7.2) have a significantly higher relative risk of thyroid gland invasion. Radiorecurrent tumours and hypopharyngeal tumours did not have an increased risk of thyroid gland invasion.
CONCLUSION: Advanced laryngeal and hypopharyngeal carcinomas involving the subglottis carry a significantly elevated risk of thyroid gland invasion compared with those that spare this subsite. The overall incidence of thyroid gland invasion is low, and therefore, thyroidectomy should be reserved for cases considered to be at risk as opposed to a being a routine measure for all total laryngectomies.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23998197     DOI: 10.1111/coa.12165

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  10 in total

1.  Management of thyroid gland invasion in laryngeal and hypopharyngeal squamous cell carcinoma.

Authors:  Seçil Arslanoğlu; Erdem Eren; Yılmaz Özkul; Ejder Ciğer; Aylin Kopar; Kazım Önal; Demet Etit; G Yazgı Tütüncü
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-07       Impact factor: 2.503

2.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

3.  The predictive value of MRI in detecting thyroid gland invasion in patients with advanced laryngeal or hypopharyngeal carcinoma.

Authors:  Peiliang Lin; Xiaoming Huang; Chushan Zheng; Qian Cai; Zhong Guan; Faya Liang; Yiqing Zheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-12       Impact factor: 2.503

4.  Rationale behind thyroidectomy in total laryngectomy: analysis of endocrine insufficiency and oncological outcomes.

Authors:  Smriti Panda; Rajeev Kumar; Abhilash Konkimalla; Alok Thakar; Chirom Amit Singh; Kapil Sikka; Suresh C Sharma; Aanchal Kakkar; Suman Bhasker
Journal:  Indian J Surg Oncol       Date:  2019-05-22

5.  Management of the thyroid gland during laryngectomy.

Authors:  S X Li; M A Polacco; B J Gosselin; L X Harrington; A J Titus; J A Paydarfar
Journal:  J Laryngol Otol       Date:  2017-06-08       Impact factor: 1.469

6.  Open partial horizontal laryngectomy for T2-T3-T4a laryngeal cancer: oncological outcomes and prognostic factors of two Italian hospitals.

Authors:  Marco de Vincentiis; Antonio Greco; Flaminia Campo; Francesca Candelori; Massimo Ralli; Mario Di Traglia; Andrea Colizza; Francesca Cambria; Jacopo Zocchi; Valentina Manciocco; Giuseppe Spriano; Raul Pellini
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-03       Impact factor: 2.503

Review 7.  Evidence and evidence gaps of laryngeal cancer surgery.

Authors:  Susanne Wiegand
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

8.  Laryngeal recurrence sites in patients previously treated with transoral laser microsurgery for squamous cell carcinoma.

Authors:  P Horwich; M H Rigby; C MacKay; J Melong; B Williams; M Bullock; R Hart; J Trites; S M Taylor
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-02-13

9.  Is thyroid excision mandatory with laryngectomy in carcinoma larynx?

Authors:  Surendra Singh Baghel; Pawan Singhal; Namita Verma; Ritu Sehra; Rajeev Yadav; Sunita Agarwal; Man Prakash Sharma; D P Gupta
Journal:  BMC Cancer       Date:  2020-07-28       Impact factor: 4.430

10.  Routine thyroidectomy with total laryngectomy: Is it really indicated? A randomized controlled trial.

Authors:  May El-Sebai Ali; Hisham Atef Ebada; Mahmoud Abd El-Shaheed; Ahmed Musaad AbdElFattah; El Sharawy Kamal
Journal:  Ann Med Surg (Lond)       Date:  2022-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.